Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience

Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience

Background: Joint manifestations are ill-defined adverse events that were frequently reported of bevacizumab in ovarian cancer patients. The aim of this study is to describe the incidence and severity of joint manifestations among bevacizumab treated patients as well as their relation to clinical ou...

Full description

Bibliographic Details
Main Authors: Maria Kaparelou, Michalis Liontos, Pelagia Katsimbri, Aggeliki Andrikopoulou, Alikistis Papatheodoridi, Anastasios Kyriazoglou, Aristotelis Bamias, Flora Zagouri, Meletios Athanasios Dimopoulos
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Gynecologic Oncology Reports
Subjects:
Bevacizumab
Arthralgia
Ovarian cancer
Vascular endothelial growth factor
Targeted therapy
Joint manifestation
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578922000339

Internet

http://www.sciencedirect.com/science/article/pii/S2352578922000339

Similar Items